Tag Amgen Inc

Cramer: These things could soon break the bulls’ manner, plus 4 stocks to buy

Cramer: These things could soon break the bulls’ manner, plus 4 stocks to buy

If you don’t know a soul that’s bullish — and I imply flat-out optimistic — you could want some new pals. We will soon see the demise of the inverted

Continue ReadingCramer: These things could soon break the bulls’ manner, plus 4 stocks to buy

Big pharma’s blockbuster obesity drug battle is just getting began, and it’s headed for $100 billion

Big pharma’s blockbuster obesity drug battle is just getting began, and it’s headed for $100 billion

Ozempic drug to deal with diabetes. Courtesy: Ozempic In their most up-to-date earnings experiences, Novo Nordisk and Eli Lilly proved why they’re the undisputed heavyweights within the prizefight for management

Continue ReadingBig pharma’s blockbuster obesity drug battle is just getting began, and it’s headed for $100 billion

The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals

The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals

Robert Galbraith | Reuters The Federal Trade Commission final week allowed Amgen to maneuver ahead with its $27.8 billion acquisition of Horizon Therapeutics underneath a settlement agreement –  a transfer

Continue ReadingThe FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

The Amgen emblem is displayed outdoors Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday mentioned it has

Continue ReadingFTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

CVS pushes into making cheaper versions of complex drugs with new discount Humira

CVS pushes into making cheaper versions of complex drugs with new discount Humira

Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to supply a close to similar model of the blockbuster arthritis therapy Humira that may promote

Continue ReadingCVS pushes into making cheaper versions of complex drugs with new discount Humira

These 10 medications are likely targets for Medicare price negotiations this fall

These 10 medications are likely targets for Medicare price negotiations this fall

Merck & Co. Inc. Januvia model medicine, used to deal with type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is

Continue ReadingThese 10 medications are likely targets for Medicare price negotiations this fall

Stocks making the biggest moves after hours: Apple, Amazon, Airbnb, Coinbase and more

Stocks making the biggest moves after hours: Apple, Amazon, Airbnb, Coinbase and more

Sheldon Cooper | Lightrocket | Getty Images Check out the firms making headlines in after-hours buying and selling. Amazon – The e-commerce big popped more than 7% in prolonged buying

Continue ReadingStocks making the biggest moves after hours: Apple, Amazon, Airbnb, Coinbase and more

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

In this photograph illustration, bins of the diabetes drug Ozempic relaxation on a pharmacy counter in Los Angeles, April 17, 2023. Mario Tama | Getty Images The European Union’s drug

Continue ReadingEU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

Here’s a list of weight-loss drugs in development and awaiting approval to take on Ozempic

Here’s a list of weight-loss drugs in development and awaiting approval to take on Ozempic

It’s been a busy few days in the obesity-and-diabetes drug business, with Club holding Eli Lilly (LLY) and its most important rival Novo Nordisk (NVO) publishing probably game-changing trial outcomes.

Continue ReadingHere’s a list of weight-loss drugs in development and awaiting approval to take on Ozempic